Elite Pharmaceuticals Income Taxes 2010-2024 | ELTP

Elite Pharmaceuticals income taxes from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Elite Pharmaceuticals Income Taxes 2010-2024 | ELTP

Elite Pharmaceuticals income taxes from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$79.7B
Takeda Pharmaceutical (TAK)$42.4B
Sandoz Group AG (SDZNY)$19.3B
Merck (MKKGY)$18.8B
Astellas Pharma (ALPMY)$18.3B
United Therapeutics (UTHR)$16.4B
Summit Therapeutics (SMMT)$13.6B
Neurocrine Biosciences (NBIX)$12.7B
Shionogi (SGIOY)$11.8B
Catalent (CTLT)$10.8B
Jazz Pharmaceuticals (JAZZ)$7.6B
Madrigal Pharmaceuticals (MDGL)$7.2B
Orion OYJ (ORINY)$6.7B
Corcept Therapeutics (CORT)$5.9B
Ionis Pharmaceuticals (IONS)$5.4B
Crinetics Pharmaceuticals (CRNX)$5.3B
PTC Therapeutics (PTCT)$3.3B
Dyne Therapeutics (DYN)$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
Soleno Therapeutics (SLNO)$2.4B
Arrowhead Pharmaceuticals (ARWR)$2.3B
Centessa Pharmaceuticals (CNTA)$2.1B
Evotec AG (EVO)$1.9B
NewAmsterdam Pharma (NAMS)$1.9B
Xencor (XNCR)$1.7B
Recursion Pharmaceuticals (RXRX)$1.6B
Harrow (HROW)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.6B
Cassava Sciences (SAVA)$1.5B